US Herbal Medicine Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

US Herbal Medicine Market Trends and Insights

Preventive Self-Care and Natural-Remedy Preference

Preventive health behavior is driving the US herbal medicine market, shifting focus from occasional illness responses to daily wellness routines. Older adults remain key contributors, maintaining supplement spending despite financial constraints, which highlights consistent demand. Consumers increasingly prefer products aligned with long-term wellness goals, as seen in 2024 retail trends where ashwagandha sales rose while elderberry declined. This shift favors premium, evidence-backed products over value offerings, strengthening revenue stability through regimen use rather than one-time purchases.

Aging Population and Chronic-Condition Self-Management

The aging population, projected to reach 73 million by 2030, significantly influences the US herbal medicine market.^{[2]Frontiers in Nutrition, “Factors Associated with the Use of Combined Nutritional Complementary and Alternative Medicine among Southern US Older Adults, Results from the Study of Aging II,” Frontiers in Nutrition, frontiersin.org} Older adults frequently use turmeric and Boswellia for inflammation, ginkgo biloba and ginseng for cognition, and berberine and cinnamon for blood sugar support. Many purchases are driven by consumer research rather than physician recommendations, creating opportunities for education-driven digital sales models. Transparency in herb-drug interactions is critical, as older consumers often manage multiple therapies simultaneously.

GLP-1 Support Routines Lifting Digestive and Metabolic Herbs

GLP-1 adoption is expanding the US herbal medicine market by boosting demand for digestive and metabolic wellness products. Ingredients like ginger, berberine, and ashwagandha are gaining traction for their roles in nausea relief, glucose metabolism, and appetite balance. This trend is broadening the use of botanical ingredients and supporting multi-ingredient formulations that combine symptom relief with long-term wellness benefits.

E-Commerce and DTC Discovery Expansion

Online purchasing is transforming the US herbal medicine market, driving discovery and retention. iHerb reported USD 2.9 billion in net sales for fiscal 2025, with a significant rise in subscription-based models like AutoShip & Save.^{[3]AARP Public Policy Institute, “Insights on Integrative Medicine and Older Adults,” AARP, aarp.org} Direct-to-consumer channels now dominate, offering brands better insights into customer behavior and enabling faster responses compared to traditional retail. This shift underscores the importance of digital capabilities as a core competitive advantage.

Import Dependence and Tariff Volatility for Non-Native Botanicals

In 2026, the US herbal medicine market faces significant challenges due to its reliance on imports. Approximately 40% of U.S. dietary supplement herb imports come from India, while 80% of raw supplement ingredient volume is sourced from China, exposing brands to price volatility and supply disruptions. Tariff actions have further increased costs, with Chinese botanicals facing a 145% tariff burden and Indian botanicals like turmeric, ashwagandha, and Boswellia encountering a 50% to 55% burden. India produces 78% of the world’s turmeric and is the sole cultivator of Boswellia serrata, making quick substitutions difficult. Smaller companies must navigate between reduced margins and higher retail prices, emphasizing the need for strategic inventory planning and supplier diversification.

Limited Clinical Substantiation for Many Herbal Products

Limited clinical substantiation remains a challenge for the US herbal medicine market, particularly in pharmacy-linked and institutional channels requiring stringent evidence. Under DSHEA, manufacturers must ensure product safety and labeling accuracy but are not obligated to prove efficacy through randomized trials, leading to uneven evidence depth. Recent FDA discretion allows the DSHEA disclaimer to appear once per label, simplifying labeling but not addressing the evidence gap. Products lacking credible evidence or a clear user experience struggle to secure repeat purchases, leaving premium pricing concentrated among brands with high-quality formulations and robust substantiation.

Segment Analysis

By Product Type: Pharmaceutical-Grade Standards Anchor Premium Positioning

In 2025, Herbal Pharmaceuticals held 30.44% of the US herbal medicine market. Herbal Dietary Supplements are projected to grow at a 9.42% CAGR through 2031, driven by the strong institutional presence of standardized botanical formulations in pharmacy and hospital channels. These products benefit from a focus on consistency, documentation, and third-party verification, giving pharmaceutical-grade offerings an edge in compliance-driven settings.

Herbal Dietary Supplements are expanding rapidly due to their alignment with consumer self-education, adaptogen use, and direct-to-consumer distribution. The projected growth reflects increasing consumer interest in managing stress, sleep, metabolic health, and daily wellness outside traditional prescriptions. Additionally, Herbal Functional Food and Beverages are gaining traction as mainstream food companies seek plant-based positioning and easier integration into daily routines.

By Source: Roots & Rhizomes Lead and Accelerate

Roots & Rhizomes held a 42.79% share in 2025 and are the fastest-growing source segment, with a projected 9.05% CAGR through 2031. This growth is driven by the commercial and clinical importance of root-derived actives like ginseng saponins, turmeric curcuminoids, and ashwagandha withanolides. These ingredients are widely recognized by consumers and formulators and are adaptable across various delivery formats.

The segment is expected to maintain its leadership as advancements in formulation enhance the performance of these actives in commercial products. Improved absorption and targeted biological effects support higher-value positioning while retaining familiar ingredient names. Traceable domestic cultivation for select botanicals strengthens provenance narratives, although many high-demand inputs still rely on overseas sources.

By Form: Established Formats Hold Share While Sensory Formats Grow Fastest

Tablets & Capsules accounted for 45.73% of 2025 sales, while Teas & Infusions are projected to grow at a 10.99% CAGR through 2031. Tablets and capsules remain popular in pharmacies and structured supplement routines due to their convenience, portability, and precise dosing.

Teas and infusions are growing faster as they align with lifestyle-driven wellness and sensory self-care, particularly among younger consumers. Powders and granules are also gaining importance in superfood and greens blends, although confidence in moringa products was impacted by a 2025 Salmonella recall.

By Distribution Channel: Digital Commerce Compresses the Pharmacy Lead

Hospitals & Retail Pharmacies held a 38.61% share in 2025, while Online & E-commerce is projected to grow at a 9.97% CAGR through 2031. Pharmacy-linked channels benefit from consumer trust in regulated retail environments and third-party quality markers, which address concerns about quality and ingredient variability.

Online and e-commerce channels are growing rapidly due to their ability to streamline product discovery and provide brands with greater control over education, subscriptions, and consumer data. The acquisition of Vitacost by iHerb in January 2026 further strengthened this channel by consolidating two major online health retail platforms.

By Medicinal Plant Type: Turmeric Anchored, Ginseng Ascending

In 2025, Turmeric held a 19.68% market share, supported by strong consumer familiarity with curcumin and its anti-inflammatory benefits across supplements, beverages, and personal care. Turmeric’s leadership in specialized retail channels underscores its dominance in the US herbal medicine market.

Ginseng is projected to grow at a 10.26% CAGR through 2031, driven by expanding use cases in cognition, metabolic support, gut-brain modulation, and GLP-1 companion routines. Echinacea and garlic remain key for immune and cardiovascular support, while aloe vera holds a strong position in topical applications. St. John’s Wort and Milk Thistle have also seen notable growth, reflecting sustained interest in botanicals for brain and liver health.

Geography Analysis

California, Texas, New York, and Florida dominate the U.S. herbal medicine market, showcasing the largest state-level revenue concentrations. The West, led by California and the Pacific Northwest, serves as a key innovation hub where premium natural retailers and direct-to-consumer wellness brands test new botanical ingredients before broader launches. This aligns with the market's premiumization trend, as consumers in these regions are more receptive to specialty formats, plant-based products, and emerging herbal claims.

The Northeast, particularly New York and Massachusetts, has a strong presence of integrative health practitioners and academic medical institutions that prioritize evidence-based botanical applications. This drives demand for standardized products with robust documentation, making the region significant for premium, pharmaceutical-grade, and clinically positioned herbal formulations. Additionally, New York City's multicultural environment boosts demand for Traditional Chinese Medicine botanicals and Ayurvedic herbs, often distributed through ethnic specialty retail channels.

The Midwest remains commercially vital, supporting manufacturing, fulfillment, and value-driven distribution across the central U.S. Established supplement production in the region caters to mass retail and pharmacy networks, ensuring channel coverage and compliance reliability. While FDA cGMP regulations under 21 CFR Part 111 apply nationwide, enforcement is particularly critical in areas with concentrated supplement production and packaging activities.